Cargando…
Mucosal Applications of Poloxamer 407-Based Hydrogels: An Overview
Poloxamer 407, also known by the trademark Pluronic(®) F127, is a water-soluble, non-ionic triblock copolymer that is made up of a hydrophobic residue of polyoxypropylene (POP) between the two hydrophilic units of polyoxyethylene (POE). Poloxamer 407-based hydrogels exhibit an interesting reversible...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161217/ https://www.ncbi.nlm.nih.gov/pubmed/30213143 http://dx.doi.org/10.3390/pharmaceutics10030159 |
_version_ | 1783358942951243776 |
---|---|
author | Giuliano, Elena Paolino, Donatella Fresta, Massimo Cosco, Donato |
author_facet | Giuliano, Elena Paolino, Donatella Fresta, Massimo Cosco, Donato |
author_sort | Giuliano, Elena |
collection | PubMed |
description | Poloxamer 407, also known by the trademark Pluronic(®) F127, is a water-soluble, non-ionic triblock copolymer that is made up of a hydrophobic residue of polyoxypropylene (POP) between the two hydrophilic units of polyoxyethylene (POE). Poloxamer 407-based hydrogels exhibit an interesting reversible thermal characteristic. That is, they are liquid at room temperature, but they assume a gel form when administered at body temperature, which makes them attractive candidates as pharmaceutical drug carriers. These systems have been widely investigated in the development of mucoadhesive formulations because they do not irritate the mucosal membranes. Based on these mucoadhesive properties, a simple administration into a specific compartment should maintain the required drug concentration in situ for a prolonged period of time, decreasing the necessary dosages and side effects. Their main limitations are their modest mechanical strength and, notwithstanding their bioadhesive properties, their tendency to succumb to rapid elimination in physiological media. Various technological approaches have been investigated in the attempt to modulate these properties. This review focuses on the application of poloxamer 407-based hydrogels for mucosal drug delivery with particular attention being paid to the latest published works. |
format | Online Article Text |
id | pubmed-6161217 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-61612172018-10-01 Mucosal Applications of Poloxamer 407-Based Hydrogels: An Overview Giuliano, Elena Paolino, Donatella Fresta, Massimo Cosco, Donato Pharmaceutics Review Poloxamer 407, also known by the trademark Pluronic(®) F127, is a water-soluble, non-ionic triblock copolymer that is made up of a hydrophobic residue of polyoxypropylene (POP) between the two hydrophilic units of polyoxyethylene (POE). Poloxamer 407-based hydrogels exhibit an interesting reversible thermal characteristic. That is, they are liquid at room temperature, but they assume a gel form when administered at body temperature, which makes them attractive candidates as pharmaceutical drug carriers. These systems have been widely investigated in the development of mucoadhesive formulations because they do not irritate the mucosal membranes. Based on these mucoadhesive properties, a simple administration into a specific compartment should maintain the required drug concentration in situ for a prolonged period of time, decreasing the necessary dosages and side effects. Their main limitations are their modest mechanical strength and, notwithstanding their bioadhesive properties, their tendency to succumb to rapid elimination in physiological media. Various technological approaches have been investigated in the attempt to modulate these properties. This review focuses on the application of poloxamer 407-based hydrogels for mucosal drug delivery with particular attention being paid to the latest published works. MDPI 2018-09-12 /pmc/articles/PMC6161217/ /pubmed/30213143 http://dx.doi.org/10.3390/pharmaceutics10030159 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Giuliano, Elena Paolino, Donatella Fresta, Massimo Cosco, Donato Mucosal Applications of Poloxamer 407-Based Hydrogels: An Overview |
title | Mucosal Applications of Poloxamer 407-Based Hydrogels: An Overview |
title_full | Mucosal Applications of Poloxamer 407-Based Hydrogels: An Overview |
title_fullStr | Mucosal Applications of Poloxamer 407-Based Hydrogels: An Overview |
title_full_unstemmed | Mucosal Applications of Poloxamer 407-Based Hydrogels: An Overview |
title_short | Mucosal Applications of Poloxamer 407-Based Hydrogels: An Overview |
title_sort | mucosal applications of poloxamer 407-based hydrogels: an overview |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161217/ https://www.ncbi.nlm.nih.gov/pubmed/30213143 http://dx.doi.org/10.3390/pharmaceutics10030159 |
work_keys_str_mv | AT giulianoelena mucosalapplicationsofpoloxamer407basedhydrogelsanoverview AT paolinodonatella mucosalapplicationsofpoloxamer407basedhydrogelsanoverview AT frestamassimo mucosalapplicationsofpoloxamer407basedhydrogelsanoverview AT coscodonato mucosalapplicationsofpoloxamer407basedhydrogelsanoverview |